|Min SIP Amount||₹500|
|NAV||₹129.54 (13 Jul 2020)|
|Fund Started||01 Jan 2013|
|Fund Size||₹5,699 Cr|
|Bayer CropScience Ltd.||Healthcare||Equity||4.4%|
|Ipca Laboratories Ltd.||Healthcare||Equity||3.5%|
|Shree Cement Ltd.||Construction||Equity||3.2%|
|Abbott India Ltd.||Healthcare||Equity||2.6%|
|Coromandel International Ltd.||Chemicals||Equity||2.5%|
|Tata Consumer Products Ltd.||FMCG||Equity||2.5%|
|Divi's Laboratories Ltd.||Healthcare||Equity||2.4%|
|Berger Paints India Ltd.||Chemicals||Equity||2.1%|
L&T Midcap Fund Direct Growth is a Equity Mutual Fund Scheme launched by L&T Mutual Fund. This scheme was made available to investors on 01 Jan 2013. Soumendra Nath Lahiri, Vihang Naik is the Current Fund Manager of L&T Midcap Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹5,699 Cr and the Latest NAV as of 13 Jul 2020 is ₹129.54.
The L&T Midcap Fund Direct Growth is rated High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.
Aims to generate long term capital appreciation by investing primarily in mid-cap stocks that have market capitalization between Rs. 300 Crore to Rs. 3000 Crore.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.